Therefore, further exploration of the ACE2-Ang-(1–7)-Mas receptor axis and its impact on metabolic syndrome, along with elucidating related mechanisms, could provide new therapeutic targets for the treatment of diabetes. Here, ACE2 is linked to metabolic syndrome.